1-4 of 4
Cornell Mallari
Close
Sort by
Journal Articles

Manufacture and In Vivo Support of Gene-Edited, Regulatory-like, T-Cells (edTreg) Using a Synthetic IL2 Receptor

Gene I. Uenishi, PhD, Cornell Mallari, Luis Gamboa, Samuel West, Chester Jacobs, Noelle Dahl, Greg Boucher, Samantha Chin, Rangoli Aeran, Dariusz Wodziak, Simon Gebremeskel, Karen Vo, PhD, Cade E. Ito, Laura Smith, Chandra Patel, PhD, Keith Abe, PhD, Basha Stankovich, PhD, Karen Sommer, PhD, Troy R. Torgerson, MD PhD, David J. Rawlings, MD, Andrew M. Scharenberg, MD, Greg J. Cost, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3355.
https://doi.org/10.1182/blood-2019-130945
Published: 2019
Journal Articles

Genome Editing Via NHEJ-Mediated Targeted Integration Retains Engraftment Potential of Edited Hematopoietic Stem Cells

Gene I. Uenishi, PhD, Keith Abe, Bee-Chun Sun, Cornell Mallari, Andrew M. Scharenberg, MD, Gregory J. Cost, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3480.
https://doi.org/10.1182/blood-2018-99-117488
Published: 2018
Journal Articles

Hemophilia a Clots Generated with Recombinant Factor VIIa Differed in Structure and Composition from Those Formed with Factor VIII

Lilley Leong, Irina N. Chernysh, Yifan Xu, Cornell Mallari, Billy Wong, Derek Sim, Adam Cuker, MD MS, Joseph Marturano, Thomas Lowery, Katalin Kauser, John W. Weisel
Journal: Blood
Blood (2016) 128 (22): 3798.
https://doi.org/10.1182/blood.V128.22.3798.3798
Published: 2016
Journal Articles

Glycopegylated Factor IX Enables Prolonged Efficacy After Subcutaneous Injection But Requires a Higher Than Expected Plasma Activity To Prevent Bleeding In Hemophilia B Mice

Derek S Sim, Alan Brooks, Cornell Mallari, Yifan Xu, Rick I Feldman, Doug Schneider, Chandra Patel, Eric Blasko, Elena Ho, Yan Su, Bing Liu, Volker Laux, John E Murphy
Journal: Blood
Blood (2013) 122 (21): 1104.
https://doi.org/10.1182/blood.V122.21.1104.1104
Published: 2013